BiotechTube
Home/Hematologics/Dongbin Xu
DX

Dongbin Xu

PhD, FACMG, Molecular Genetics/Cytogenetics

Hematologics

Therapeutic Areas

Hematologic MalignanciesAcute LeukemiaMyelodysplastic SyndromesMultiple Myeloma

Hematologics Pipeline

DrugIndicationPhase
MRD Testing ServiceAcute LeukemiasCommercial
Cytopenias/MDS Diagnostic ServiceMyelodysplastic Syndromes & CytopeniasCommercial
Plasma Cell Neoplasm ServiceMultiple Myeloma & Plasma Cell DisordersCommercial
Biopharmaceutical Clinical Trial ServicesHematologic Malignancies (Clinical Trial Support)Commercial
Integrated HLA LOH Assay (with Versiti)Informs Immunotherapy DecisionsCommercial

Leadership Team at Hematologics

MR
Michael R. Loken
PhD, Scientific Founder/Leader
DA
Denise A. Wells
MD, Clinical Pathologist
CH
Chad Hudson
MD
BS
Ben Stueben
MD
View full Hematologics profile